Adverse events62

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 62

Type	Event	Organ system	Group	Affected	At risk	Events
other	Headache	Nervous system disorders	Nemolizumab	13	187	16
other	Headache	Nervous system disorders	Placebo	2	95	2
other	Cough	Respiratory, thoracic and mediastinal disorders	Nemolizumab	9	187	11
other	Cough	Respiratory, thoracic and mediastinal disorders	Placebo	5	95	6
other	Neurodermatitis	Skin and subcutaneous tissue disorders	Nemolizumab	15	187	17
other	Neurodermatitis	Skin and subcutaneous tissue disorders	Placebo	18	95	21
other	Eczema	Skin and subcutaneous tissue disorders	Nemolizumab	10	187	10
other	Eczema	Skin and subcutaneous tissue disorders	Placebo	1	95	1
other	COVID-19	Infections and infestations	Nemolizumab	14	187	14
other	COVID-19	Infections and infestations	Placebo	14	95	14
other	Nasopharyngitis	Infections and infestations	Nemolizumab	11	187	12
other	Nasopharyngitis	Infections and infestations	Placebo	8	95	8
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Nemolizumab	6	187	12
other	Dyspnoea	Respiratory, thoracic and mediastinal disorders	Placebo	5	95	5
serious	Basal cell carcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Nemolizumab	1	187	1
serious	Basal cell carcinoma	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Placebo	0	95	0
serious	Squamous cell carcinoma of skin	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Nemolizumab	1	187	1
serious	Squamous cell carcinoma of skin	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Placebo	0	95	0
serious	Oedema peripheral	General disorders	Nemolizumab	0	187	0
serious	Oedema peripheral	General disorders	Placebo	1	95	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04501666/events

API reference For AI assistants

Adverse events62

Sources 3

Read this list from software.